Abstract: The present invention relates to agents for use in the treatment of glioma, in particular astrocytoma WHO II° and III°, as well as IV° (glioblastoma), in a subject.

Abstract: The present invention relates to agents for use in the treatment of glioma, in particular astrocytoma WHO I? and 111°, as well as IV0 (glioblastoma), in a subject.

Abstract: The present invention relates to agents for use in the treatment of glioma, in particular astrocytoma WHO IF and 111°, as well as IV0 (glioblastoma), in a subject.

Abstract: A filter housing has a housing pot accommodating a filter element. The filter housing has a connecting element connectable by a rotary and/or plug-in connection for connecting the filter with a connecting device. The filter housing has a securing ring forming a cup-shaped attachment section with a circumferential free rim. By rotary and/or plug-in movement, the attachment section is attached to an insertion section of the connecting device. The attachment section is provided with a sealing receptacle of a circumferential sealing device. The sealing receptacle is open in radial inward direction and has a radial sealing surface. The attachment section is connected at the free rim with the circumferential wall of the housing pot by crimping. The securing ring provides a first axial stop surface for an annular seal. A stop ring, inserted into the securing ring, provides a second axial stop surface for the annular seal.

Abstract: Described herein are novel imidazopyridine derivatives of the formula I ##STR1## wherein R is ##STR2## and R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in Patent Claim 1, and their salts, which exhibit antagonistic properties towards angiotensin II and can be used for the treatment of hypertension, aldosteronism, cardiac insufficiency and increased intraocular pressure, and of disorders of the central nervous system.